Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Uranium Energy Corp (UEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Uranium Energy Corp — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Uranium Energy Corp trades at $9.25 (market cap $4.69B). The key difference: Uranium Energy Corp is far larger — about 2.7× Nuvation Bio Inc. Class A Common Stock's market cap, and Nuvation Bio Inc. Class A Common Stock is trading nearer its 52-week high, Uranium Energy Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Uranium Energy Corp for 37 Days on average.
| NUVB | UEC | |
|---|---|---|
Market Cap | $1.71B | $4.69B |
Volume | 5,448,712 | 8,957,476 |
Sector | Health | Energy |
52-Week High | $9.54 | $20.14 |
52-Week Low | $3.41 | $9.04 |
Typical Hold Time | 0 Days | 37 Days |
Enterprise Value | $1.30B | $4.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Uranium Energy (UEC) trades at $9.47, down 6.33% today, amid bearish technical signals despite strong analyst support. The company reported fiscal 2026 revenue of $37M with a net loss of $137M, reflecting operational expansion but negative profitability. Recent news highlights UEC's transition to a multi-mine producer with improved production scale and a $93.13 realized uranium price, though earnings quality concerns persist due to inventory-driven revenue.
UEC presents a high-risk, high-reward opportunity with Wall Street optimism (87.5% buy ratings, $16.06 consensus target) contrasting weak fundamentals. Key risks include sustained losses, unproven production sustainability, and uranium price volatility. The stock's upside depends on successful execution of U.S. uranium production ramp-up amid growing nuclear demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Uranium Energy Corp
Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →
